1. Yaster M, Deshpande JK. Management of pediatric pain with opioid analgesics.JPediatr. 1988;113:421-429.
2.
2. Vree TB, Verwey-Van Wissen CP. Pharmacokinetics and metabolism of codeine in humans. Biopharm Drug Dispos. 1992;13:445-460.
3.
3. Bodd E, Jocobsen D, Lund E, et al. Morphine-6-glucuronide might mediate the prolonged effect of morphine in renal failure. Hum Exp Toxicol. 1987;9:317-321.
4.
4. Matzke GR, Chan GLC, Abraham PA. Codeine dosage in renal failure (letter). ClinPharm. 1986;5:15-16.
5.
5. Levine DF.Hypocalcemia increases the narcotic effect of codeine. Postgrad Medj1980;56:736-737.
6.
6. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 9th ed.New York: McGraw-Hill; 1996:521-555.
7.
7. Findlay JWA, Jones EC, Butz RF, et al. Plasma codeine and morphine concentrations after therapeutic oral doses of codeine containing analgesics. Clin Pharm Ther. 1987;24:60-68.
8.
8. Lynn AM, Opheim KE, Tyler DC. Morphine infusion after cardiac surgery. Crit Care Med. 1984;12:863-866.
9.
9. Osborne RJ, Joel SP, Slevin ML. Morphine intoxication in renal failure: The role of morphine-6-glucuronide. BrMedj. 1986;292:1548-1549.
10.
10. Muller-Wiefel DE: Hemofiltration and other methods of blood purification. In: Holliday MA, Barratt TM, Vernier RL, eds. Pediatric Nephrology, 2nd ed.Baltimore: Williams and Wilkins; 1987:810-810.